Effectiveness of elbasvir/grazoprevir in patients with chronic hepatitis C and chronic kidney disease: results from the veterans affairs system

被引：0
|
作者：
Kramer, J. R. [1 ,2 ]
Puenpatom, A. [3 ]
Erickson, K. [1 ,2 ]
Cao, Y. [2 ]
Smith, D. L. [1 ,2 ]
Chaudhri, E. [3 ]
El-Serag, H. B. [1 ,2 ]
Kanwal, F. [1 ,2 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Michael E DeBakey VA Med Ctr, Houston, TX USA
[3] Merck & Co Inc, Kenilworth, NJ USA
来源：
JOURNAL OF VIRAL HEPATITIS | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1-063
引用
收藏
页码：54 / 55
页数：2
相关论文
共 50 条
  • [1] Effectiveness of Elbasvir/Grazoprevir in patients with Chronic Hepatitis C and Chronic Kidney Disease: Results from the Veterans Affairs system
    Kramer, Jennifer R.
    Puenpatom, Amy
    Erickson, Kevin
    Cao, Yumei
    Smith, Donna L.
    El-Serag, Hashem B.
    Kanwal, Fasiha
    [J]. HEPATOLOGY, 2017, 66 : 597A - 597A
  • [2] Elbasvir/Grazoprevir effectiveness in patients with Chronic Hepatitis C and Chronic Kidney Disease: real-world experience from the TRIO Network
    Younossi, Z.
    Bacon, B.
    Curry, M.
    Dieterich, D.
    Flamm, S.
    Kowdley, K.
    Milligan, S.
    Nwankwo, C.
    Tsai, N.
    Afdhal, N.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S748 - S749
  • [3] Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population
    Choi, Debra T.
    Puenpatom, Amy
    Yu, Xian
    Erickson, Kevin F.
    Kanwal, Fasiha
    El-Serag, Hashem B.
    Kramer, Jennifer R.
    [J]. ANTIVIRAL RESEARCH, 2020, 174
  • [4] COST-EFFECTIVENESS OF GRAZOPREVIR / ELBASVIR IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS
    Mattingly, T. J., III
    Slejko, J. F.
    Mullins, C. D.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A415 - A415
  • [5] REAL-WORLD EFFECTIVENESS OF ELBASVIR/GRAZOPREVIR IN PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 4 INFECTION: RESULTS FROM A VETERANS AFFAIRS POPULATION
    Kramer, Jennifer R.
    Puenpatom, Amy
    Cao, Yumei
    El-Serag, Hashem B.
    Kanwal, Fasiha
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S1341 - S1342
  • [6] Real-world effectiveness of elbasvir/grazoprevir in patients with hepatitis C virus genotype 4 infection: Results from a Veterans Affairs population
    Kramer, Jennifer
    Puenpatom, Amy
    Cao, Yumei
    El-Serag, Hashem
    Kanwal, Fasiha
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E236 - E237
  • [7] Effectiveness of Elbasvir/Grazoprevir in US Veterans with Chronic Hepatitis C Virus Genotype 1b Infection
    Puenpatom, Amy
    Cao, Yumei
    Yu, Xian
    Kanwal, Fasiha
    El-Serag, Hashem B.
    Kramer, Jennifer R.
    [J]. INFECTIOUS DISEASES AND THERAPY, 2020, 9 (02) : 355 - 365
  • [8] Effectiveness of Elbasvir/Grazoprevir in US Veterans with Chronic Hepatitis C Virus Genotype 1b Infection
    Amy Puenpatom
    Yumei Cao
    Xian Yu
    Fasiha Kanwal
    Hashem B. El-Serag
    Jennifer R. Kramer
    [J]. Infectious Diseases and Therapy, 2020, 9 : 355 - 365
  • [9] Projected impact of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 and chronic kidney disease in Vietnam
    Nwankwo, Chizoba
    Corman, Shelby L.
    Elbasha, Elamin H.
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2019, 12 (04) : 502 - 508
  • [10] Cost-Effectiveness of Elbasvir/Grazoprevir for the Treatment of Chronic Hepatitis C: A Systematic Review
    Liu, Jinyu
    Guo, Min
    Ke, Lei
    You, Ruxu
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10
12345